Related Experiment Video
Updated: Jan 8, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Pharmacokinetic-Driven Individualized Anticoagulation Plan for Pediatric Athletes on Direct Oral Anticoagulants
Devin Donnelly1, Riten Kumar1,2
1Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
Insights
Children on anticoagulation can safely participate in contact sports with individualized plans. Pharmacokinetic data guided safe management, with no major bleeding events observed during sports participation or injury management.
Area of Science:
- Pediatric Hematology
- Sports Medicine
- Pharmacology
Background:
- Children on anticoagulation are often restricted from contact sports due to bleeding concerns.
- Direct oral anticoagulants (DOACs) offer predictable pharmacokinetics for tailored treatment.
Purpose of the Study:
- To assess the safety and feasibility of individualized anticoagulation plans for pediatric athletes in contact sports.
- To evaluate the use of pharmacokinetic (PK) data in managing anticoagulation for young athletes.
Main Methods:
- Individualized anticoagulation plans were developed using PK data for five pediatric athletes.
- Patients were followed for a median of 27 months, including periods of anticoagulation interruption for sports injuries.
Main Results:
- Two patients experienced four sports-related injuries during anticoagulation interruption.
- No clinically significant bleeding or recurrent thrombosis occurred.
- All patients safely resumed anticoagulation after injury.
Conclusions:
- Individualized anticoagulation management based on PK data enables pediatric athletes to participate in contact sports.
- This approach appears safe, with no major bleeding complications observed.
- Careful management allows for safe resumption of anticoagulation post-injury.
Abstract:
Children on anticoagulation have traditionally been discouraged from participating in contact and collision sports due to a perceived bleeding risk. The predictable pharmacokinetics of direct oral anticoagulants permit more individualized management. At Boston Children's Hospital, pharmacokinetic (PK) data were used to develop individualized anticoagulation plans for five athletes on anticoagulation who wished to participate in contact or collision sports. Median (range) duration of follow-up for the cohort was 27 (1-42) months. During this period, two patients sustained four sports-related injuries during anticoagulation interruption, but no clinically significant bleeding or recurrent/progressive thrombosis was observed. All patients safely resumed anticoagulation post-injury.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Venous Thrombosis III: Interprofessional Care
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Anticoagulant Drugs: Low-Molecular-Weight Heparins

